Karen S. Lynch is the CEO of CVS Health, taking the helm in 2021 after her role as President of Aetna. With over 30 years of experience in healthcare, she leads one of the nation's largest health companies, driving CVS's...

Current Market Cap

$77.26B

Number of Employees

300K

Total Compensation

2021 - 2023

Trending down by -33.74% last year
Showing total compensation for the last 2021 - 2023

Stock

Down by -41.11% last year

Salary

Up by 0.84% last year

Bonus

Up by 0.57% last year

Other

Up by 75.70% last year

Year

2023

Total Compensation

$20.47M

Salary

$1.50M

Board Justification

The compensation philosophy emphasizes pay-for-performance, aligning executive compensation with company performance, peer benchmarking, and retention strategies.

Bonus

$2.99M

Board Justification

The annual cash incentive award is based on the achievement of pre-established financial, operating, and individual performance objectives, with a final payout of 99.7% of target due to corporate performance results of 83.1% and an individual performance modifier of 120%.

Other

$623.07K

Board Justification

Other compensation includes perquisites such as personal use of corporate aircraft, a corporate driver, and contributions to defined contribution plans.

Restricted Stock

$15.35M(206.61K RSU)

Board Justification

The stock awards that vested in 2023 include RSUs and PSUs, with a total value realized upon vesting of $15,353,189.

Performance Metrics

Performance metrics for 2023 included MIP Adjusted Operating Income (80% weighting) and Net Promoter Score (20% weighting).

SEC Filing

From April 5, 2024

Karen S. Lynch

CEO of CVS Health

C

Education

Bachelor's degree in Nursing from Boston College, MBA from the University of Massachusetts Amherst

Field of Expertise

Healthcare & Life Sciences - Healthcare

Born

December 30, 1965 - 58 years ago

Is Founder?

No

Current Tenure

3 years 4 months (May 2021 - Present)

Previous Experience

President of Aetna, various leadership roles at Cigna

View Holdings

Insider Holdings of Karen S. Lynch

CVS

$19.16M

-$1.11M (-5.47%)

Last Insider Trade

CVS

$3.60M

CVS at $79.56/share

Apr 1, 2024

Received